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Abstract
Background:  Totally implantable venous access devices are widely used for infusion of
chemotherapy or parenteral nutrition. Device associated complications include technical operative
problems, infections, paravasal infusions and catheter or punction chamber dislocation.
Case presentation: We present the case of a 49-year-old patient with the rare complication of
a intrapulmonal catheter dislocation of a totally implantable venous access system. Treosulfane for
chemotherapy of metastatic breast cancer was infused via the catheter causing instant coughing and
dyspnoea which lead to the diagnosis of catheter dislocation. The intrapulmonal part of the
catheter was removed under thoracoscopic control without further complications.
Conclusion: Intrapulmonal catheter dislocation is a rare complication of a totally implantable
venous access device which can not be avoided by any prophylactic measures. Therefore, the
infusion system should be tested before each use and each new symptom, even when not obviously
related to the catheter should be carefully documented and evaluated by expert physicians to avoid
severe catheter-associated complications.
Background
Totally implantable venous access devices are widely used
for infusion of chemotherapy or parenteral nutrition [1-
4]. Implantation and use of these systems offer a high
level of safety and convenience for patients and physi-
cians. Device associated complications include technical
operative problems, infections, paravasal infusions and
catheter or punction chamber dislocation [1,2]. We
present the case of a patient with the rare complication of
an intrapulmonal catheter dislocation in a totally
implantable venous access system.
Case presentation
A 49-year-old female with metastatic breast cancer (supr-
aclavicular lymph node metastases) presented with dysp-
noea, intermittent coughing and general weakness. The
patient had undergone chemotherapy with treosulfane via
a totally implantable venous access port catheter the day
before.
The venous silicone catheter system (Fresenius Intraport,
Fresenius Kabi, Bad Homburg, Germany) had been
implanted 2 years before via the left cephalic vein by
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tangential incision of the vein after distal ligation without
intra- or postoperative complications in our department.
Correct placement had been documented by x-ray of the
chest immediately after the implantation (figure 1). Fol-
lowing implantation, the catheter had been used for three
months without any problems. Thereafter, the system was
regularly flushed with heparin-saline solution. On presen-
tation, injection into the port catheter was freely possible
but caused instant reflectory coughing. Aspiration of
blood via the port was not possible. Laboratory findings
showed a mild leukocytosis of 11.0/nl and hypokalemia
of 2.6 mmol/l.
Further radiological diagnostics including injection of
contrast medium into the catheter documented a disloca-
tion of the catheter tip into the upper lobe of the right
lung with paravasation into the bronchial system (figure
2). In addition, thoracic computerised tomographic (CT)
scan showed a large pleural effusion in the right pleural
cavity (figure 3). There was no evidence for mediastinal or
intrapulmonal tumour growth or lymph node metastases
at the site of perforation. The patient was referred to the
department of thoracic surgery for further therapy. The
intrapulmonal tip of the port catheter was cut off and
extracted thoracoscopically. The remaining catheter
Postoperative x-ray after catheter implantation Figure 1
Postoperative x-ray after catheter implantation. The catheter tip is placed correctly in the superior caval vein.World Journal of Surgical Oncology 2005, 3:19 http://www.wjso.com/content/3/1/19
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retracted into the superior caval vein lumen. As the patient
had undergone mammarial gland ablation on both sides
with consecutive radiation there was a severe dermatitis
with ulcerations at the implantation site of the port cath-
eter. Due to the high-risk of infection and wound healing
complications and the limited life-expectancy of the
patient, it was decided to leave the injection chamber and
catheter remnant in situ without any further use for injec-
tions or infusions. The patient recovered from the inter-
vention without complications.
Discussion
Totally implantable venous access devices are broadly
used for application of chemotherapy or intravenous
nutrition, especially in patients with poor peripheral vein
conditions [1-4]. Early, mainly surgical complications can
occur, such as bleeding, pneumothorax, nerve lesions or
catheter misplacement. Wound and catheter infection (4–
5%), thrombosis (3–3.5%), catheter fracture or discon-
nection (0.5%) and secondary dislocation (1.5–2%) of
the catheter are the most important long-term
Injection of contrast medium via the port catheter Figure 2
Injection of contrast medium via the port catheter. Paravasal and intrabronchial drainage of the applied contrast.World Journal of Surgical Oncology 2005, 3:19 http://www.wjso.com/content/3/1/19
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complications [1,2]. In the presented case, the catheter tip
of the venous access device perforated the superior caval
vein and dislocated into the upper lobe of the right lung.
To our knowledge, this pulmonary complication has not
been reported in the literature before. Common events of
secondary dislocation include migration of the catheter
tip into the internal jugular vein or the contralateral sub-
clavian vein. A perforation of the caval vein and migration
of the catheter into mediastinal structures or the pericar-
dium has been reported [5-7]. The venous access device
was implanted 2-years before and the correct placement of
the catheter at the atrial-caval junction was documented
CT scan showing the catheter tip in the right upper lobe of the lung and a large dorsobasal pleural effusion Figure 3
CT scan showing the catheter tip in the right upper lobe of the lung and a large dorsobasal pleural effusion.World Journal of Surgical Oncology 2005, 3:19 http://www.wjso.com/content/3/1/19
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by intra- and postoperative x-ray (figure 1). Moreover, the
system worked properly since then, excluding a surgical
problem in the presented case. The reason for the perfora-
tion remains obscure. CT scan showed no local inflamma-
tion, pathologic lymph nodes or tumour growth at the site
of perforation. A spontaneous catheter perforation may be
explained by a cranial dislocation of the catheter tip. A sig-
nificant increase in catheter malfunctions has been
reported by Petersen et al, [8] when catheters are placed
primarily in a too high position in the caval vein. In the
presented case this position might have resulted from a
secondary dislocation. As the catheter was introduced via
the left subclavian vein, its tip could get into a right angled
position to the right lateral vessel wall of the caval vein. In
this position a mechanical irritation leading to a chronic
decubitus of the vessel wall with consequent perforation
into the lung is possible. A similar event of an intrabron-
chial migration has been reported with a broken intraa-
trial pacing device [9]. However, these pacing catheter tips
contain metallic material and therefore are more rigid
than silicone port catheters, favouring a spontaneous per-
foration of these devices.
Another explanation for a chronic damage of the vessel
wall might be endothelial cytotoxicity of the applied
chemotherapy itself. In recent studies such an effect has
been observed, especially when vinorelbin or 5-fluorour-
acil had been administered via a central venous catheter
[10-12] leading to injury of the right phrenic nerve by
direct cytotoxic effects. The authors of these studies postu-
lated a damage of the endothelial barrier by the chemo-
therapeutic agent. In the presented case, first-line
chemotherapy had included paclitaxel and epirubicin.
Additionally, treosulfane had been administered immedi-
ately before the perforation became evident. None of
these agents has yet been reported to cause endothelial
damage as mentioned above. Therefore, a direct cytotoxic
effect to the vessel wall seems rather unlikely.
Possible consecutive complications of the perforation
itself include the risk of bleeding and air embolism as well
as the paravasal application of fluids and especially
aggressive chemotherapeutic agents via the dislocated
catheter. There are case reports of accidental
intrapericardial and intramediastinal applications of
chemotherapeutic drugs as well as subcutaneous applica-
tions of chemotherapy due to wrong positioning of the
puncture needle [5-7]. In most of the cases, patients did
not suffer from adverse effects of these paravasats. In the
presented case, treosulfane was administered intrabron-
chially, leading to coughing and dyspnoea, as well as a
large pleural effusion which was absorbed without con-
secutive problems. Especially no interstitial pneumonia or
evident tissue necrosis occurred.
Guidelines on how to avoid accidental paravasal infusion
during the long-term use of port catheters include punc-
ture and spilling of the catheter with saline solution,
which is broadly accepted as a safety test before using the
catheter. Blood aspiration before injection can be per-
formed in addition. However, many catheters shows a
"ventil" mechanism following long-term use. Therefore,
blood aspiration may not be possible, although the cath-
eter can still be used for infusion. A standard chest x-ray
may be used to discover catheter dislocation, but does not
reveal functional problems. The gold standard for diagno-
sis of catheter dislocation and function is the radiographic
visualization with contrast medium application via the
catheter. This is certainly no routine procedure prior to
each application of chemotherapeutic drugs as it is associ-
ated with x-ray exposure of the patient, the risk of con-
trast-medium related complications, requires radiological
facilities and high costs. Therefore, the only recommenda-
tion is to puncture and use port catheters with the highest
accuracy. Each new symptom, even when not obviously
related to the catheter, e.g. coughing following infusion,
should be carefully documented and evaluated by expert
physicians to avoid severe catheter-associated
complications.
Conclusion
Intrapulmonal dislocation of the catheter tip is a rare
complication of a totally implantable venous access
device. However, it can cause severe complications and
may be difficult to recognize due to unspecific symptoms.
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